These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24841819)

  • 21. Intravitreal ocriplasmin: A breakthrough in the treatment of vitreomacular traction?
    Mec-Słomska AE; Adamiec-Mroczek J; Kuźmicz E; Misiuk-Hojło M
    Adv Clin Exp Med; 2017; 26(3):527-531. PubMed ID: 28791829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review.
    Schneider EW; Johnson MW
    Clin Ophthalmol; 2011; 5():1151-65. PubMed ID: 21887098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pars plana vitrectomy for vitreomacular traction syndrome.
    Kovacević D; Markusić V
    Coll Antropol; 2013 Apr; 37 Suppl 1():271-3. PubMed ID: 23837256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative imaging of enzymatic vitreolysis-induced fiber remodeling.
    Filas BA; Shah NS; Zhang Q; Shui YB; Lake SP; Beebe DC
    Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8626-37. PubMed ID: 25468895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Looking at ocriplasmin as a new option in eye disease.
    Mitchell MD; Miller DM
    Drugs Today (Barc); 2012 Aug; 48(8):519-24. PubMed ID: 22916339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microplasmin for vitreomacular traction.
    Udaondo P; Diaz-Llopis M; Garcia-Delpech S; Salom D; Arevalo JF
    Ophthalmology; 2010 Sep; 117(9):1859, 1859.e1; author reply 1859-60. PubMed ID: 20816250
    [No Abstract]   [Full Text] [Related]  

  • 27. Intravitreal injection of expansile perfluoropropane (c(3)f(8)) for the treatment of vitreomacular traction.
    Rodrigues IA; Stangos AN; McHugh DA; Jackson TL
    Am J Ophthalmol; 2013 Feb; 155(2):270-276.e2. PubMed ID: 23164159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocriplasmin (Jetrea) for vitreomacular adhesion.
    Med Lett Drugs Ther; 2013 Aug; 55(1422):63-4. PubMed ID: 23917386
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacological vitrectomy.
    Tanaka M; Qui H
    Semin Ophthalmol; 2000 Mar; 15(1):51-61. PubMed ID: 10749315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental evaluation of microplasmin - an alternative to vital dyes.
    Gandorfer A
    Dev Ophthalmol; 2008; 42():153-159. PubMed ID: 18535388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel possibility of vitreomacular traction treatment.
    Michalska-Małecka K; Witek K; Sierocka-Stępień J; Wyględowska-Promieńska D; Nowak M
    Acta Ophthalmol; 2016 Dec; 94(8):e818-e819. PubMed ID: 27167161
    [No Abstract]   [Full Text] [Related]  

  • 32. Injectable drug may help avoid eye surgery in patients with vitreomacular adhesion.
    Morrow T
    Manag Care; 2013 Jan; 22(1):49-50. PubMed ID: 23373143
    [No Abstract]   [Full Text] [Related]  

  • 33. Autologous plasmin for pharmacologic vitreolysis prepared 1 hour before surgery.
    Rizzo S; Pellegrini G; Benocci F; Belting C; Baicchi U; Vispi M
    Retina; 2006 Sep; 26(7):792-6. PubMed ID: 16963853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme-induced vitreolysis can alleviate the progression of diabetic retinopathy through the HIF-1α pathway.
    Li C; Chen P; Zhang J; Zhang L; Huang X; Yao Y; Che X; Fan X; Ge S; Wang Z
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4964-70. PubMed ID: 23847321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal autologous plasmin prepared by urokinase for vitreolysis: a pilot study.
    Maleki A; Tohidi-Zand SR; Amirizadeh N; Dehghan-Haghighi J; Zanjani H; Arish M; Salari AM; Mirhosseini SM; Abrishami M
    Eur J Ophthalmol; 2016; 26(1):67-70. PubMed ID: 26044374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How should we release vitreomacular traction: surgically, pharmacologically, or pneumatically?
    Johnson MW
    Am J Ophthalmol; 2013 Feb; 155(2):203-205.e1. PubMed ID: 23312439
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacologic vitreodynamics and molecular flux.
    Goldenberg DT; Trese MT
    Dev Ophthalmol; 2009; 44():31-36. PubMed ID: 19494650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vitreomacular Traction Syndrome (VMTS)].
    Maier MM; Feucht N; Burzer S; Lohmann CP
    Klin Monbl Augenheilkd; 2013 Sep; 230(9):920-8. PubMed ID: 23842874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrasurgical plasmin enzyme in diabetic macular edema.
    Azzolini C; D'Angelo A; Maestranzi G; Codenotti M; Della Valle P; Prati M; Brancato R
    Am J Ophthalmol; 2004 Oct; 138(4):560-6. PubMed ID: 15488781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of vitreous in the pathogenesis of neovascular age-related macular degeneration].
    Boneva S; Haritoglou C; Schultheiss M; Binder S; Sebag J
    Ophthalmologie; 2023 Oct; 120(10):992-998. PubMed ID: 37801159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.